Loading...
Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques
BACKGROUND: Tecovirimat (ST-246) is being developed as an antiviral therapeutic for smallpox for use in the event of an accidental or intentional release. The last reported case of smallpox was 1978 but the potential for use of variola virus for biowarfare has renewed interest in smallpox antiviral...
Na minha lista:
| Udgivet i: | J Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6151088/ https://ncbi.nlm.nih.gov/pubmed/29982575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy326 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|